Zymeworks Inc. (ZYME)
NASDAQ: ZYME · IEX Real-Time Price · USD
9.78
-0.03 (-0.31%)
At close: Jul 19, 2024, 4:00 PM
10.27
+0.49 (5.01%)
Pre-market: Jul 22, 2024, 9:02 AM EDT
Zymeworks Employees
As of December 31, 2023, Zymeworks had 278 total employees, including 272 full-time and 6 part-time employees. The number of employees decreased by 16 or -5.44% compared to the previous year.
Employees
278
Change (1Y)
-16
Growth (1Y)
-5.44%
Revenue / Employee
$181,525
Profits / Employee
-$453,144
Market Cap
691.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Weave Communications | 844 |
Paragon 28 | 574 |
SI-BONE | 344 |
Scholar Rock Holding | 150 |
Stoke Therapeutics | 110 |
Alumis | 109 |
ORIC Pharmaceuticals | 100 |
Arbutus Biopharma | 73 |
ZYME News
- 3 hours ago - Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate - GlobeNewsWire
- 11 days ago - Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 - GlobeNewsWire
- 5 weeks ago - Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers - GlobeNewsWire
- 6 weeks ago - Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer - GlobeNewsWire
- 7 weeks ago - Zymeworks Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- ZYME - Accesswire
- 7 weeks ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Levi & Korsinsky Reminds Zymeworks Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ZYME - Accesswire
- 2 months ago - Lost Money on Zymeworks Inc.(ZYME)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - Accesswire